The anti-tumor efficacy of TRAM-34 in terms of reduction of migration, invasiveness, and phagocytosis of TAMs depends on FAK and AKT phosphorylation (Grimaldi et al., 2016) as well as tumor infiltration in the brain parenchyma (D’Alessandro et al., 2013). This evidence concerns the gene AKT1 and neoplasm.